A Study To Investigate The Effect of JNJ-39758979 on Histamine Induced Itch in Healthy Male Volunteers

NCT01068223 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Histamine Induced Itch

Interventions

DRUG: A:JNJ-39758979/Placebo #1
DRUG: C:Cetirizine/JNJ-39758979 Matching Placebo
DRUG: B: JNJ-39758979 Matching Placebo /Placebo #2

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.